Schedule 13G ownership disclosure
APREA THERAPEUTICS INC
Security class unavailable · CUSIP: 03836J102
Event date: 2019-10-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,519,323
- Percent of class
- 12.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-19-054651
- Form type
- SC 13G
- Filer
- Aprea Therapeutics, Inc.
- CIK
- CIK 1781983
- Filed
- Oct 17, 2019
- Reporting period
- Oct 07, 2019
- Description
- Schedule 13G beneficial ownership